Literature DB >> 23026889

From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Michael F Green, Gerhard Hellemann, William P Horan, Junghee Lee, Jonathan K Wynn.   

Abstract

CONTEXT Schizophrenia remains a highly disabling disorder, but the specific determinants and pathways that lead to functional impairment are not well understood. It is not known whether these key determinants of outcome lie on 1 or multiple pathways. OBJECTIVE To evaluate theoretically based models of pathways to functional outcome starting with early visual perception. The intervening variables were previously established determinants of outcome drawn from 2 general categories: ability (ie, social cognition and functional capacity) and beliefs/motivation (ie, defeatist beliefs, expressive and experiential negative symptoms). We evaluated an integrative model in which these intervening variables formed a single pathway to poor outcome. DESIGN This was a cross-sectional study that applied structural equation modeling to evaluate the relationships among determinants of functional outcome in schizophrenia. SETTING Assessments were conducted at a Veterans Administration Medical Center. PARTICIPANTS One hundred ninety-one clinically stable outpatients with schizophrenia or schizoaffective disorder were recruited from the community. RESULTS A measurement model showed that the latent variables of perception, social cognition, and functional outcome were well reflected by their indicators. An initial untrimmed structural model with functional capacity, defeatist beliefs, and expressive and experiential negative symptoms had good model fit. A final trimmed model was a single path running from perception to ability to motivational variables to outcome. It was more parsimonious and had better fit indices than the untrimmed model. Further, it could not be improved by adding or dropping connections that would change the single path to multiple paths. The indirect effect from perception to outcome was significant. CONCLUSIONS The final structural model was a single pathway running from perception to ability to beliefs/motivation to outcome. Hence, both ability and motivation appear to be needed for community functioning and can be modeled effectively on the same pathway.

Entities:  

Year:  2012        PMID: 23026889      PMCID: PMC3976993          DOI: 10.1001/archgenpsychiatry.2012.652

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  57 in total

1.  UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults.

Authors:  T L Patterson; S Goldman; C L McKibbin; T Hughs; D V Jeste
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

2.  Neurocognitive correlates of recovery from schizophrenia.

Authors:  Alex Kopelowicz; Robert P Liberman; Joseph Ventura; Roberto Zarate; Jim Mintz
Journal:  Psychol Med       Date:  2005-08       Impact factor: 7.723

Review 3.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

4.  Recovery from schizophrenia: a concept in search of research.

Authors:  Robert Paul Liberman; Alex Kopelowicz
Journal:  Psychiatr Serv       Date:  2005-06       Impact factor: 3.084

5.  Emotional intelligence in schizophrenia.

Authors:  Kimmy S Kee; William P Horan; Peter Salovey; Robert S Kern; Mark J Sergi; Alan P Fiske; Junghee Lee; Kenneth L Subotnik; Keith Nuechterlein; Catherine A Sugar; Michael F Green
Journal:  Schizophr Res       Date:  2008-09-21       Impact factor: 4.939

6.  Intrinsic motivation as a predictor of work outcome after vocational rehabilitation in schizophrenia.

Authors:  Alice M Saperstein; Joanna M Fiszdon; Morris D Bell
Journal:  J Nerv Ment Dis       Date:  2011-09       Impact factor: 2.254

7.  Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.

Authors:  Paul M Grant; Gloria A Huh; Dimitri Perivoliotis; Neal M Stolar; Aaron T Beck
Journal:  Arch Gen Psychiatry       Date:  2011-10-03

8.  Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.

Authors:  William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green
Journal:  J Psychiatr Res       Date:  2009-12-14       Impact factor: 4.791

9.  Social disinterest attitudes and group cognitive-behavioral social skills training for functional disability in schizophrenia.

Authors:  Eric Granholm; Dror Ben-Zeev; Peter C Link
Journal:  Schizophr Bull       Date:  2009-07-23       Impact factor: 9.306

10.  Getting the cue: sensory contributions to auditory emotion recognition impairments in schizophrenia.

Authors:  David I Leitman; Petri Laukka; Patrik N Juslin; Erica Saccente; Pamela Butler; Daniel C Javitt
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

View more
  145 in total

1.  Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.

Authors:  Samantha E Yohn; Daniela Alberati; Merce Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2017-01-12       Impact factor: 4.530

2.  Social Disconnection in Schizophrenia and the General Community.

Authors:  Michael F Green; William P Horan; Junghee Lee; Amanda McCleery; L Felice Reddy; Jonathan K Wynn
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

3.  Subcortical association with memory performance in schizophrenia: a structural magnetic resonance imaging study.

Authors:  Daisuke Koshiyama; Masaki Fukunaga; Naohiro Okada; Fumio Yamashita; Hidenaga Yamamori; Yuka Yasuda; Michiko Fujimoto; Kazutaka Ohi; Haruo Fujino; Yoshiyuki Watanabe; Kiyoto Kasai; Ryota Hashimoto
Journal:  Transl Psychiatry       Date:  2018-01-10       Impact factor: 6.222

4.  The P1 visual-evoked potential, red light, and transdiagnostic psychiatric symptoms.

Authors:  Jeffrey S Bedwell; Christopher C Spencer; Chi C Chan; Pamela D Butler; Pejman Sehatpour; Joseph Schmidt
Journal:  Brain Res       Date:  2018-03-03       Impact factor: 3.252

5.  Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.

Authors:  Charles M Olbert; David L Penn; Robert S Kern; Junghee Lee; William P Horan; Steven P Reise; Kevin N Ochsner; Stephen R Marder; Michael F Green
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

6.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

Authors:  Michael F Green; Junghee Lee; Kevin N Ochsner
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

7.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 8.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

9.  Cross-diagnostic comparison of visual processing in bipolar disorder and schizophrenia.

Authors:  Carol Jahshan; Jonathan K Wynn; Amanda McCleery; David C Glahn; Lori L Altshuler; Michael F Green
Journal:  J Psychiatr Res       Date:  2014-01-02       Impact factor: 4.791

10.  Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome.

Authors:  Gregory P Strauss; William P Horan; Brian Kirkpatrick; Bernard A Fischer; William R Keller; Pinar Miski; Robert W Buchanan; Michael F Green; William T Carpenter
Journal:  J Psychiatr Res       Date:  2013-02-27       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.